1. Home
  2. ATOS vs GPMT Comparison

ATOS vs GPMT Comparison

Compare ATOS & GPMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATOS
  • GPMT
  • Stock Information
  • Founded
  • ATOS 2009
  • GPMT 2015
  • Country
  • ATOS United States
  • GPMT United States
  • Employees
  • ATOS N/A
  • GPMT N/A
  • Industry
  • ATOS Biotechnology: Pharmaceutical Preparations
  • GPMT Real Estate Investment Trusts
  • Sector
  • ATOS Health Care
  • GPMT Real Estate
  • Exchange
  • ATOS Nasdaq
  • GPMT Nasdaq
  • Market Cap
  • ATOS 107.2M
  • GPMT 122.0M
  • IPO Year
  • ATOS 2012
  • GPMT 2017
  • Fundamental
  • Price
  • ATOS $0.78
  • GPMT $2.84
  • Analyst Decision
  • ATOS Strong Buy
  • GPMT Buy
  • Analyst Count
  • ATOS 3
  • GPMT 3
  • Target Price
  • ATOS $6.17
  • GPMT $3.13
  • AVG Volume (30 Days)
  • ATOS 1.3M
  • GPMT 268.6K
  • Earning Date
  • ATOS 08-12-2025
  • GPMT 08-05-2025
  • Dividend Yield
  • ATOS N/A
  • GPMT 7.03%
  • EPS Growth
  • ATOS N/A
  • GPMT N/A
  • EPS
  • ATOS N/A
  • GPMT N/A
  • Revenue
  • ATOS N/A
  • GPMT N/A
  • Revenue This Year
  • ATOS N/A
  • GPMT N/A
  • Revenue Next Year
  • ATOS N/A
  • GPMT $30.02
  • P/E Ratio
  • ATOS N/A
  • GPMT N/A
  • Revenue Growth
  • ATOS N/A
  • GPMT N/A
  • 52 Week Low
  • ATOS $0.55
  • GPMT $1.61
  • 52 Week High
  • ATOS $1.66
  • GPMT $3.66
  • Technical
  • Relative Strength Index (RSI)
  • ATOS 45.59
  • GPMT 58.67
  • Support Level
  • ATOS $0.81
  • GPMT $2.66
  • Resistance Level
  • ATOS $0.80
  • GPMT $2.87
  • Average True Range (ATR)
  • ATOS 0.03
  • GPMT 0.11
  • MACD
  • ATOS -0.00
  • GPMT -0.00
  • Stochastic Oscillator
  • ATOS 39.58
  • GPMT 83.54

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.

Share on Social Networks: